SCHEMBL4849446

SCHEMBL4849446

NCOC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O

nearest known ligand 0.69

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.69
SLC28A2 O43868 1/20 0.69
SLC29A1 Q99808 1/20 0.69
SLC28A3 Q9HAS3 1/20 0.69
P2RY6 Q15077 8/20 0.67
P2RY2 P41231 12/20 0.65
P2RY4 P51582 5/20 0.65
P2RY14 Q15391 5/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18660235 0.91 SLC28A1 (0.66) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL12988228 0.89 SLC28A1 (0.67) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL1532521 0.89 SLC28A1 (0.74) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL4064962 0.89 SLC28A1 (0.63) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL7611038 0.88 P2RY14 (0.61) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL121732 0.88 SLC28A1 (0.69) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL12259056 0.88 SLC28A1 (0.69) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL4950157 0.88 SLC28A1 (0.72) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL4741075 0.88 SLC28A1 (0.72) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6
SCHEMBL5612643 0.87 SLC28A1 (0.71) SLC28A1SLC28A2SLC29A1SLC28A3P2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200038429-A1 P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION Bio-Path Holdings, Inc. (US) 2020-02-06 US disclosed
US-10335428-B2 P-ethoxy nucleic acids for liposomal formulation Bio-Path Holdings, Inc. (US) 2019-07-02 US disclosed
US-20180161360-A1 P-ETHOXY NUCLEIC ACIDS FOR LIPOSOMAL FORMULATION Bio-Path Holdings, Inc. (US) 2018-06-14 US disclosed
CN-102575252-B For polynucleotide, the compoistion and method of use of multivalence RNA interference HALO-BIO RNAI THERAPEUTICS, INC. (US) 2016-04-20 CN disclosed
CN-104830812-A Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities ATYR PHARMA INC 2015-08-12 CN disclosed
US-8592384-B2 Micro-RNA's that regulate muscle cells THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-11-26 US disclosed
CN-102575252-A Polynucleotides for multivalent RNA interference, compositions and methods of use thereof HALO BIO RNAI THERAPEUTICS INC 2012-07-11 CN disclosed
US-7452705-B2 N4 virion single-stranded DNA dependent RNA polymerase THE UNIVERSITY OF CHICAGO (US) 2008-11-18 US disclosed
US-20060246491-A1 Micro-RNA's that regulate muscle cells THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2006-11-02 US disclosed
EP-0828856-B1 NUCLEIC ACID DETECTION AND AMPLIFICATION BY CHEMICAL LINKAGE OF OLIGONUCLEOTIDES BIO RAD LABORATORIES (US) 2005-12-21 EP disclosed
EP-0828856-A4 NUCLEIC ACID DETECTION AND AMPLIFICATION BY CHEMICAL LINKAGE OF OLIGONUCLEOTIDES BIO RAD LABORATORIES (US) 2001-11-21 EP disclosed
US-5843650-A Nucleic acid detection and amplification by chemical linkage of oligonucleotides SEGEV DAVID (IL) 1998-12-01 US disclosed
EP-0828856-A1 NUCLEIC ACID DETECTION AND AMPLIFICATION BY CHEMICAL LINKAGE OF OLIGONUCLEOTIDES BIO-RAD LABORATORIES, INC. (US) 1998-03-18 EP disclosed
WO-1996034984-A1 NUCLEIC ACID DETECTION AND AMPLIFICATION BY CHEMICAL LINKAGE OF OLIGONUCLEOTIDES BIO-RAD LABORATORIES INC. (US) 1996-11-07 WO disclosed